Latest News

BrightFocus Foundation is hosting its third annual dinner to celebrate and showcase some of the world’s most promising science to end Alzheimer’s disease, macular degeneration and glaucoma.

Learn how medications, diseases, and trauma can cause an eye condition called secondary glaucoma, explore how laser procedures are used in the treatment of glaucoma, understand how volunteers are supporting an important clinical trial to save sight, and much more in the spring 2018 edition of National Glaucoma Research Report.

BrightFocus Foundation today announced that EyesOnALZ, the first-ever crowdsourced project to engage the public in Alzheimer’s research, hit a major milestone by exceeding 10,000 citizen scientists joining to help speed up the time-consuming data analysis of stalled blood vessels in the brain. BrightFocus is the key funder of this effort.

An international team of scientists will today receive the prestigious 2018 Helen Keller Prize for Vision Research. The prize, presented by BrightFocus Foundation, honors scientific excellence and is chosen by an awards committee of the Helen Keller Foundation for Research and Education.

BrightFocus Foundation recognizes six scientists studying macular degeneration and glaucoma, awarding research grants named in honor of leaders in vision science.

BrightFocus Foundation today announced $13.5 million in new scientific research grants seeking cures for Alzheimer’s disease, macular degeneration, and glaucoma.

The spring edition of Alzheimer's Disease Research Review provides information about a major advance in drug development that started with funding from Alzheimer's Disease Research (ADR), explains why clinical trial volunteers are key for curing Alzheimer’s, summarizes recommendations for home-based dementia care that were unveiled at an event sponsored by ADR, offers some tips and advice for informing your loved one about their Alzheimer’s diagnosis, and more.